Lithium Americas Corp vs Twist Bioscience Corp — how do they compare? Lithium Americas Corp trades at $3.07 (market cap $1.01B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: Twist Bioscience Corp is far larger — about 5.4× Lithium Americas Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals.
| LAC | TWST | |
|---|---|---|
Market Cap | $1.01B | $5.45B |
Sector | Basic Materials | Health |
52-Week High | $10.05 | $102.88 |
52-Week Low | $2.55 | $24.16 |
Enterprise Value | $1.13B | $5.37B |
Trailing returns across standard periods
Latest headlines on both assets
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →